financetom
Business
financetom
/
Business
/
Vishay Intertechnology Insider Sold Shares Worth $597,096, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vishay Intertechnology Insider Sold Shares Worth $597,096, According to a Recent SEC Filing
Mar 6, 2024 6:29 AM

09:07 AM EST, 03/06/2024 (MT Newswires) -- Marc Zandman, Director, ExecChairman & Chief Bus Dev, on March 04, 2024, sold 26,154 shares in Vishay Intertechnology ( VSH ) for $597,096. Following the Form 4 filing with the SEC, Zandman has control over a total of 73,678 shares of the company, with 73,678 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/103730/000010373024000059/xslF345X03/form4.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Kraft Heinz to Introduce New Line of Healthier Foods
Market Chatter: Kraft Heinz to Introduce New Line of Healthier Foods
Mar 17, 2026
07:11 AM EDT, 03/17/2026 (MT Newswires) -- Kraft Heinz ( KHC ) will introduce a line of healthy food products as part of a revitalization plan, Bloomberg reported Tuesday, citing an interview with Chief Executive Officer Steve Cahillane. The new products will be rolled out this month and in April, Bloomberg reported. The new products include high-protein Kraft Mac &...
Form 8.3
Form 8.3
Mar 17, 2026
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION   (a) Full name of discloser: Massachusetts Financial Services Company (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Victory Capital Submits Improved, Actionable and Clearly Superior Proposal to Acquire Janus Henderson
Victory Capital Submits Improved, Actionable and Clearly Superior Proposal to Acquire Janus Henderson
Mar 17, 2026
Enhanced Financial Terms Provide Higher Value and Greater Certainty for Janus Henderson Shareholders; Materially Exceeds Value of Trian’s Contemplated Transaction Gives Special Committee Another Opportunity to Consider Improved, Superior Proposal from Independent Third Party SAN ANTONIO--(BUSINESS WIRE)-- Victory Capital Holdings, Inc. ( VCTR ) (“Victory Capital” or the “Company”) today sent a letter to the Special Committee of the...
Rhythm Pharmaceuticals Rare Obesity Drug Study Disappoints
Rhythm Pharmaceuticals Rare Obesity Drug Study Disappoints
Mar 17, 2026
Rhythm Pharmaceuticals Inc. ( RYTM ) shares are down during Tuesday’s premarket session following the Monday announcement of topline results from its EMANATE trial. EMANATE was a Phase 3 trial designed to evaluate the efficacy and safety of setmelanotide in patients with rare, genetically driven obesities of the MC4R pathway. EMANATE Trial Misses Primary Endpoints In the EMANATE trial, Rhythm...
Copyright 2023-2026 - www.financetom.com All Rights Reserved